CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishizaki, K.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizaki, K.
Right arrow Articles by Fujita, T.

Canadian Journal of Anesthesia, Vol 43, 724-730, Copyright © 1996 by Canadian Anesthesiologists' Society

ARTICLES

Intrathecally administered NMDA receptor antagonists reduce the MAC of isoflurane in rats

K Ishizaki, N Yoshida, DM Yoon, MH Yoon, M Sudoh and T Fujita
Department of Anesthesiology and Reanimatology, School of Medicine, Gunma University, Japan.

PURPOSE: We studied the effects of intrathecal administration of an N-methyl-D-aspartate (NMDA) receptor antagonist and an antagonist of the glycine site of the NMDA receptor on the minimum alveolar anaesthetic concentration (MAC) of isoflurane in rats, and on locomotor activity in conscious rats. METHODS: In Wistar rats fitted with indwelling intrathecal catheters, we determined the MAC of isoflurane after the administration of saline (control group); the competitive NMDA receptor antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosponic acid(CPP) at 0.01, 0.1, and 1.0 nM; and the selective antagonist of the glycine site on the NMDA receptor complex 7-chlorokynurenic acid (7CKA) at 0.1, 1.0, and 10 nM. After measurement of MAC following administration of the antagonist, the equipotent reversal dose of NMDA or D-serine was administered. The rats were examined for the presence of locomotor dysfunction by intrathecal administration of NMDA receptor antagonists, NMDA and D-serine in conscious rats. All of the experiments were performed using randomization and masking of drugs. RESULTS: CPP at 0.1 and 1.0 nM decreased the MAC of isoflurane by 9.9-17.6% (P < 0.05). 7CKA at 1.0 and 10 nM reduced MAC from 10.5-15.5% (P < 0.05). Intrathecal administration of NMDA or D-serine reversed the decreases in MAC to control values. Locomotor activity was not changed. CONCLUSIONS: We believe that NMDA receptor plays an important role in determining the MAC of isoflurane in the spinal cord.


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
J. M. Sonner, J. F. Antognini, R. C. Dutton, P. Flood, A. T. Gray, R. A. Harris, G. E. Homanics, J. Kendig, B. Orser, D. E. Raines, et al.
Inhaled Anesthetics and Immobility: Mechanisms, Mysteries, and Minimum Alveolar Anesthetic Concentration
Anesth. Analg., September 1, 2003; 97(3): 718 - 740.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
C. Stabernack, J. M. Sonner, M. Laster, Y. Zhang, Y. Xing, M. Sharma, and E. I. Eger II
Spinal N-Methyl-D-Aspartate Receptors May Contribute to the Immobilizing Action of Isoflurane
Anesth. Analg., January 1, 2003; 96(1): 102 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. Zhang, S. Wu, E. I Eger II, and J. M. Sonner
Neither GABAA nor Strychnine-Sensitive Glycine Receptors Are the Sole Mediators of MAC for Isoflurane
Anesth. Analg., January 1, 2001; 92(1): 123 - 127.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Canadian Anesthesiologists' Society.